Julie Rubinstein, President and COO at Adaptive Biotechnologies Corp (ADPT), sold 57,180 shares at $13.18 ($770K) on 2026-03-19, disclosed to the SEC on 2026-03-23.
Scheduled sale ($770k) by President and COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.18 | 19,060 | $251K | 32.6% |
| 2 | $13.37 | 19,060 | $255K | 33.1% |
| 3 | $13.83 | 19,060 | $264K | 34.2% |
| Total | $13.46 avg | 57,180 | $770K | 100% |
| Filing → |
| ADPT | SELL | 2026-10-05 | $1.0M | — | Filing → |
| ADPT | SELL | 2026-04-29 | $271K | — | Filing → |
| ADPT | SELL | 2026-04-24 | $798K | — | Filing → |